Ask the Expert

Why Is MRD Testing Important for Myeloma Patients?

How can myeloma patients benefit from an MRD test? How do the results impact care? Watch now to learn from myeloma experts Dr. Gareth Morgan and Dr. Mohit Trikha.

Mohit Trikha, PhD, Gareth Morgan, MD, PhD, FRCP, FRCPath, Esther Schorr, Andrew Schorr

Making Sense of New Myeloma Treatments During Coronavirus

New myeloma medicines are being approved despite the coronavirus pandemic. Watch as our panel discusses new therapies, COVID-19 safety measures and more.

Saad Z. Usmani, MD, FACP, Jack Aiello, Andrew Schorr

Latest News

Side Effects of Myeloma Treatment: What is Too Much?

Yolanda Brunson-Sarrabo, CPT- NASM, Cesar Rodriguez, MD

What is Myeloma?

Paul Richardson, MD

New Drug Combinations for Treating Multiple Myeloma

James Berenson, MD, Andrew Schorr

Monoclonal Gammopathy of Undetermined Significance (MGUS)

James Berenson, MD, Andrew Schorr

Managing the Side Effects of Myeloma Treatment

Rafael Fonseca, MD, FACP, Andrew Schorr

How the BOSTON Study Impacts Myeloma Patients

Andrew Schorr, Paul Richardson, MD

COVID-19 Lessons for Myeloma Patients

Andrew Schorr, Rafael Fonseca, MD, FACP

Myeloma Treatment Amid the Coronavirus Pandemic

Megan Trusdell, Robert Orlowski, MD, PhD

The Value and Phases of Multiple Myeloma Clinical Trials

Shebli Atrash, MD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Maddie Hunter

Update on Coronavirus Issues for Myeloma Patients

Faith Davies, MD, MBBCh, MRCP, FRCPath, Noopur Raje, MD

Myeloma Experts Discuss Coronavirus and Impact on Patient Care

Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Shebli Atrash, MD, Maddie Hunter

How Are Doctors Personalizing Smoldering Myeloma Care?

Larry Anderson, Jr., MD, PhD, Nina Shah, MD, Faith Davies, MD, MBBCh, MRCP, FRCPath, Jennifer Ahlstrom